Prepared by IPRO
Buprenorphine for Pain: A Transition Guide from Full Agonist Opioid Prescriptions is a tool intended to aid clinicians in switching patients off of full opioid agonists to buprenorphine, a partial mixed opioid agonist for pain management.
The information presented in this document should not be considered medical advice and is not a substitute for individualized patient or client care and treatment decisions.
Prepared by IPRO
The Buprenorphine Resource Guide is a resource that contains the various FDA-approved formulations of buprenorphine for Opioid Use Disorder and pain management. This resource guide also includes a brief history of buprenorphine and explains its analgesic effects.
Prepared by IPRO
Join us for this special presentation featuring real-world strategies for preventing hospital delirium! Delirium affects as many as 50% of hospitalized patients over the age of 65. Furthermore, delirium accounts for increased length of stay, hospital readmissions, emergency department visits and institutionalization of older adults. Delirium is often precipitated by opioid use for pain management. Don’t miss this discussion on alternatives, using an example of a successful hospital project. These initiatives will inspire you to take on delirium prevention at your facility!
Prepared by Anne Myrka, RPh, MAT, IPRO
This patient education document describes what Naloxone is, how it works, why it is offered to individuals with an opioid prescription, and signs of opioid overdose.
Spanish language version available here.
Prepared by IPRO NQIIC
Conversation Starter to assist clinicians in counseling patients on the use of opioid medication prior to discharge, in the ER or in the clinic setting.
Prepared by IPRO QIN-QIO, Centers for Medicare & Medicaid Services Quality Improvement & Innovation Group
Use with Quality Improvement and Care Coordination: Implementing the CDC Guideline for Prescribing Opioids for Chronic Pain document and the Opioid and Pain Management Best Practice Aggregate Results Dashboard.
Centers for Disease Control and Prevention
The NHSN application provides various options that allow NHSN users to analyze their surveillance data. The resources listed on the link above are intended to help you use the analysis tool, and interpret data analyzed from the Patient Safety Component of NHSN.
Centers for Disease Control and Prevention (CDC)
This interactive, web-based training features self-paced learning, case-based content, knowledge checks, and integrated resources to help healthcare providers gain a deeper understanding of the CDC Guideline for Prescribing Opioids for Chronic Pain. Find tips on implementing the Guideline in primary care practice and overcoming challenges. Earn free CE.
Clinical practice guidelines encourage use of the PDMP prior to prescribing to assess a patient’s history of controlled substance use. It is possible to improve the way opioids are prescribed, reducing the number of people who misuse, abuse, or overdose from them, while making sure patients have access to safe, effective pain management. A prescription drug monitoring program (PDMP) is an electronic database that tracks controlled substance prescriptions. PDMPs can help identify patients who may be misusing prescription opioids or other prescription drugs and who may be at risk for overdose.
IPRO Hospital Quality Improvement (HQIC), Learning and Action Network (LAN) webinar on the All-Cause Harm focus are of Opioid Stewardship: April 26th 2021.
IPRO HQIC presented aggregate baseline data on the Opioid Stewardship Hospital Baseline Assessment and heard from a rural hospital on promoting the safe use of opioids (prescribing policy, scripted communication tools, alternatives to opioids, tracking prescribing practices, referral network for pain management, and MAT therapy).
In addition, IPRO HQIC highlight many salient opioid stewardship resources on processes that support the inclusion of patient and family engagement and health equity (stigma) in opioid stewardship efforts. These resources further support IPRO HQIC hospital efforts in All-Cause Harm reduction.
Recording, Slides and All-Cause Harm Resource available.
Health and Human Services (HHS) April, 2021
In an effort to get evidenced-based treatment to more Americans with opioid use disorder, the Department of Health and Human Services (HHS) is releasing new buprenorphine practice guidelines that among other things, remove a longtime requirement tied to training, which some practitioners have cited as a barrier to treating more people.
Signed by HHS Secretary Xavier Becerra, the Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder exempt eligible physicians, physician assistants, nurse practitioners, clinical nurse specialists, certified registered nurse anesthetists and certified nurse midwives from federal certification requirements related to training, counseling and other ancillary services that are part of the process for obtaining a waiver to treat up to 30 patients with buprenorphine.
Centers for Disease Control and Prevention (CDC)
Healthcare executives have an important role in creating a culture for safer opioid prescribing. This handbook contains insights and advice from healthcare executives and quality improvement leaders from four different health systems representing urban, suburban and rural settings. They share their experiences engaging internal and external stakeholders, working across interdisciplinary teams, leveraging data to inform efforts, implementing training and educational efforts, and much more. Sections include:
